Literature DB >> 24420725

Dermatologic manifestations of fibromyalgia.

Valerie Laniosz1, David A Wetter, Desiree A Godar.   

Abstract

The aim of this study was to determine the common dermatologic diagnoses and skin-related symptoms in a cohort of patients with fibromyalgia seen in a tertiary referral center. A retrospective chart review was performed of all patients with a fibromyalgia diagnosis from January 1 to December 31, 2008, whose diagnosis was confirmed in the Fibromyalgia and Chronic Fatigue Clinic at Mayo Clinic in Rochester, Minnesota. Charts were reviewed for dermatologic conditions and cutaneous symptoms. Demographic and clinical data were collected to assess the frequency of skin-related issues in patients with fibromyalgia. Of 2,233 patients screened, 845 patients met the inclusion criteria of having a confirmed diagnosis of fibromyalgia. Among these fibromyalgia patients, various dermatologic conditions and cutaneous problems were identified, including hyperhidrosis in 270 (32.0 %), burning sensation of the skin or mucous membranes in 29 (3.4 %), and various unusual cutaneous sensations in 14 (1.7 %). Pruritus without identified cause was noted by 28 patients (3.3 %), with another 16 patients (1.9 %) reporting neurotic excoriations, prurigo nodules, or lichen simplex chronicus. Some form of dermatitis other than neurodermatitis was found in 77 patients (9.1 %). Patients with fibromyalgia may have skin-related symptoms associated with their fibromyalgia. No single dermatologic diagnosis appears to be overrepresented in this population, with the exception of a subjective increase in sweating.

Entities:  

Mesh:

Year:  2014        PMID: 24420725     DOI: 10.1007/s10067-014-2488-3

Source DB:  PubMed          Journal:  Clin Rheumatol        ISSN: 0770-3198            Impact factor:   2.980


  17 in total

1.  Abnormal microcirculation and temperature in skin above tender points in patients with fibromyalgia.

Authors:  M Jeschonneck; G Grohmann; G Hein; H Sprott
Journal:  Rheumatology (Oxford)       Date:  2000-08       Impact factor: 7.580

2.  Dysautonomia in fibromyalgia syndrome: sympathetic skin responses and RR interval analysis.

Authors:  Umit Hidir Ulas; Ece Unlu; Kemal Hamamcioglu; Zeki Odabasi; Aytul Cakci; Okay Vural
Journal:  Rheumatol Int       Date:  2005-06-30       Impact factor: 2.631

3.  Mitochondrial dysfunction in skin biopsies and blood mononuclear cells from two cases of fibromyalgia patients.

Authors:  Mario D Cordero; Ana M Moreno-Fernández; María I Carmona-López; José Antonio Sánchez-Alcázar; Ana Fernández Rodríguez; Plácido Navas; Manuel de Miguel
Journal:  Clin Biochem       Date:  2010-07-01       Impact factor: 3.281

4.  The correlation of laboratory tests and Sympathetic Skin Response parameters by using artificial neural networks in fibromyalgia patients.

Authors:  Ozhan Ozkan; Murat Yildiz; Etem Köklükaya
Journal:  J Med Syst       Date:  2011-01-05       Impact factor: 4.460

5.  Fibromyalgia in lupus erythematosus.

Authors:  A Gräfe; U Wollina; B Tebbe; H Sprott; C Uhlemann; G Hein
Journal:  Acta Derm Venereol       Date:  1999-01       Impact factor: 4.437

6.  Is inflammation a mitochondrial dysfunction-dependent event in fibromyalgia?

Authors:  Mario D Cordero; Eduardo Díaz-Parrado; Angel M Carrión; Simona Alfonsi; José Antonio Sánchez-Alcazar; Pedro Bullón; Maurizio Battino; Manuel de Miguel
Journal:  Antioxid Redox Signal       Date:  2012-11-16       Impact factor: 8.401

7.  A comparative study of clinical signs in fibromyalgia/fibrositis syndrome, healthy and exercising subjects.

Authors:  G Granges; G O Littlejohn
Journal:  J Rheumatol       Date:  1993-02       Impact factor: 4.666

8.  Characteristic electron microscopic findings in the skin of patients with fibromyalgia: preliminary study.

Authors:  Seong-Ho Kim; Dong Hoon Kim; Dong-Ho Oh; Daniel J Clauw
Journal:  Clin Rheumatol       Date:  2007-10-03       Impact factor: 2.980

9.  Detection of interleukin 1beta (IL-1beta), IL-6, and tumor necrosis factor-alpha in skin of patients with fibromyalgia.

Authors:  Souzan Salemi; Janine Rethage; Uwe Wollina; Beat A Michel; Renate E Gay; Steffen Gay; Haiko Sprott
Journal:  J Rheumatol       Date:  2003-01       Impact factor: 4.666

10.  Microcirculation abnormalities in patients with fibromyalgia - measured by capillary microscopy and laser fluxmetry.

Authors:  Susanne Morf; Beatrice Amann-Vesti; Adrian Forster; Ulrich K Franzeck; Renate Koppensteiner; Daniel Uebelhart; Haiko Sprott
Journal:  Arthritis Res Ther       Date:  2004-12-10       Impact factor: 5.156

View more
  5 in total

1.  Unbiased immune profiling reveals a natural killer cell-peripheral nerve axis in fibromyalgia.

Authors:  Vivek Verma; Gillian L Drury; Marc Parisien; Ayşe N Özdağ Acarli; Tho-Alfakar Al-Aubodah; Anastasia Nijnik; Xia Wen; Nicol Tugarinov; Maria Verner; Richie Klares; Alexander Linton; Emerson Krock; Carlos E Morado Urbina; Bendik Winsvold; Lars G Fritsche; Egil A Fors; Ciriaco Piccirillo; Arkady Khoutorsky; Camilla I Svensson; Mary A Fitzcharles; Pablo M Ingelmo; Nicole F Bernard; Franck P Dupuy; Nurcan Üçeyler; Claudia Sommer; Irah L King; Carolina B Meloto; Luda Diatchenko
Journal:  Pain       Date:  2021-09-24       Impact factor: 7.926

2.  Sleep Related Scratching: A Distinct Parasomnia?

Authors:  Gaurav Nigam; Muhammad Riaz; Shelley D Hershner; Cathy A Goldstein; Ronald D Chervin
Journal:  J Clin Sleep Med       Date:  2016-01       Impact factor: 4.062

3.  Evaluation of fibromyalgia syndrome in patients with rosacea.

Authors:  Emine Müge Acar; Hilal Kaya Erdoğan; Senem Şaş; Ersoy Acer
Journal:  Arch Rheumatol       Date:  2021-01-14       Impact factor: 1.472

4.  High Frequency of Fibromyalgia in Patients With Acne Vulgaris.

Authors:  Levent Yazmalar; Tahsin Çelepkolu; İbrahim Batmaz; Mustafa Akif Sariyildiz; Bilal Sula; Mahmut Alpayci; İsa An; Yahya Kemal Burkan; Haydar Uçak; Remzi Çevik
Journal:  Arch Rheumatol       Date:  2016-02-22       Impact factor: 1.472

Review 5.  Neuropathic Itch.

Authors:  James Meixiong; Xinzhong Dong; Hao-Jui Weng
Journal:  Cells       Date:  2020-10-09       Impact factor: 6.600

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.